Leukemia, Chronic Myeloid research hub

A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

This study in Germany looks at how well a medicine called asciminib works for people with a type of blood cancer called chronic myeloid leukemia (CML), specifically if they have a special 'Philadelphia chromosome' gene. It compares it to other treatments for newly diagnosed or previously treated patients.